Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Pinterest Inc (PINS) Price & Performance

Heron Therapeutics IncTrade
Pinterest IncTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Pinterest Inc — how do they compare? Heron Therapeutics Inc trades at $0.36 (market cap $68.01M), while Pinterest Inc trades at $20.76 (market cap $11.63B). The key difference: Pinterest Inc is far larger — about 171× Heron Therapeutics Inc's market cap, and Pinterest Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Pinterest Inc for 85 Days on average.

HRTXPINS
Market Cap
$68.01M$11.63B
Volume
1,891,94112,792,940
Sector
HealthMedia
52-Week High
$1.49$35.24
52-Week Low
$0.27$15.42
Typical Hold Time
35 Days85 Days
Enterprise Value
$174.75M$11.55B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.

While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.

Pinterest Inc

Pinterest (PINS) trades at $20.31, up 1.4% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue growth accelerated to $4.22 billion in 2025, with a net income margin of 9.87%, while analyst consensus is a Buy with a $27.93 price target. Recent news highlights its undervaluation and new Visual Search Ads launch, though insider selling and cash flow volatility present mixed signals.

The outlook is positive given robust fundamentals and growth potential, but risks include competitive pressures and reliance on ad revenue. Upside is supported by earnings momentum and international monetization, yet investors should monitor cash flow trends and market sentiment shifts for sustained gains.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HRTX
8% Buy92% Sell
Avg holding period · 35 Days
PINS
0% Buy100% Sell
Avg holding period · 85 Days

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →

About Pinterest Inc

Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.

Read more on PINS →